SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2020
Commission File Number: 001-38051
(Translation of registrant’s name into English)
Room 8888, Jiudingfeng Building, 888 Changbaishan Road,
Qingdao Area, China (Shandong) Pilot Free Trade Zone
People’s Republic of China
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Closing of Private Placement
As disclosed on SOS Limited’s (the “Company”) Current Report on Form 6-K (the “Initial 6-K”) filed with the Securities and Exchange Commission on October 21, 2020, the Company entered into certain securities purchase agreement (the “SPA”) on October 15, 2020 with certain “non-U.S. Persons” (the “Purchasers”) as defined in Regulation S of the Securities Act of 1933, as amended, pursuant to which the Company agreed to sell an aggregate of 65,337,649 units (the “Units”), each Unit consisting of one Class A ordinary share of the Company, par value $0.0001 per share (“Share”) and a warrant to purchase one Share (“Warrant”) with an initial exercise price of $0.281 per Share, or $2.81 per American depositary share of the Company (“ADS”) at a price of $0.2254 per Unit, or $2.254 per ADS, for an aggregate purchase price of RMB100,000,000 (approximately $14,727,106), subject to various conditions to closing.
On November 5, 2020, the transaction contemplated by the SPA consummated when all the closing conditions of the SPA have been satisfied and the Company issued 65,337,649 Shares and Warrants to the Purchasers pursuant to the SPA.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: November 5, 2020
|By:||/s/ Yandai Wang|
|Title:||Chief Executive Officer|